Search research articles
Contact Us
Filters
Showing results (41-50 of 175) with videos related to
Page
of 18
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
October 14, 2022
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study
Soraya Benguerfi, Thierry Lesimple, Roch Houot, et al.
Bulletin Du Cancer
|
December 24, 2025
[Estimating the real price of CAR-T cells in France: From list price to net price]
Carole-Anne Brugère, Pascal Deschaseaux, Emmanuel Gomez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study
Sébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, et al.
Oncoimmunology
|
April 11, 2018
NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment
Dang-Nghiem Vo, Catherine Alexia, Nerea Allende-Vega, et al.
The International Journal of Clinical and Experimental Hypnosis
|
January 9, 2023
Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced Aplasia
Magali Granger, Norah Anthony, Cécile Lermenier, et al.
Clinical Biochemistry
|
September 15, 2022
Comparison of different equations for renal function evaluation as proxies for antibiotic drug clearance: The examples of amoxicillin and cloxacillin
Xavier Duval, Bénédicte Franck, Matthieu Revest, et al.
Ejhaem
|
September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study
Clémence Haméon, Roch Houot, Emmanuel Gyan, et al.
Clinical Nuclear Medicine
|
November 28, 2023
Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma
Mehdi Mouheb, Morgane Pierre-Jean, Anne Devillers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 2010
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
Jonathan M Irish, June H Myklebust, Ash A Alizadeh, et al.
Blood
|
August 3, 2018
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
Franck Morschhauser, Gilles Salles, Steven Le Gouill, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 175) with videos related to
Sort By:
Page
of 18
Acta Oncologica (Stockholm, Sweden)
|
October 14, 2022
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study
Soraya Benguerfi, Thierry Lesimple, Roch Houot, et al.
Bulletin Du Cancer
|
December 24, 2025
[Estimating the real price of CAR-T cells in France: From list price to net price]
Carole-Anne Brugère, Pascal Deschaseaux, Emmanuel Gomez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study
Sébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, et al.
Oncoimmunology
|
April 11, 2018
NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment
Dang-Nghiem Vo, Catherine Alexia, Nerea Allende-Vega, et al.
The International Journal of Clinical and Experimental Hypnosis
|
January 9, 2023
Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced Aplasia
Magali Granger, Norah Anthony, Cécile Lermenier, et al.
Clinical Biochemistry
|
September 15, 2022
Comparison of different equations for renal function evaluation as proxies for antibiotic drug clearance: The examples of amoxicillin and cloxacillin
Xavier Duval, Bénédicte Franck, Matthieu Revest, et al.
Ejhaem
|
September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study
Clémence Haméon, Roch Houot, Emmanuel Gyan, et al.
Clinical Nuclear Medicine
|
November 28, 2023
Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma
Mehdi Mouheb, Morgane Pierre-Jean, Anne Devillers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 2010
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
Jonathan M Irish, June H Myklebust, Ash A Alizadeh, et al.
Blood
|
August 3, 2018
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
Franck Morschhauser, Gilles Salles, Steven Le Gouill, et al.
Page
of 18